Lymphatic vascular morphogenesis in development, physiology, and disease

Journal of Cell Biology

Volumn 193, Issue 4, 2011, Pages 607-618

  Schulte Merker, Stefan ^a,b,c   Sabine, Amélie ^d   Petrova, Tatiana V ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Centre for Biomedical Genetics   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIUM CELL; HEMATOPOIETIC CELL; HUMAN; LYMPH FLOW; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOLEIOMYOMATOSIS; MASSIVE OSTEOLYSIS; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ANIMALS; BIOLOGICAL TRANSPORT; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HOMEOSTASIS; HUMANS; LYMPH; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; LYMPHEDEMA; MORPHOGENESIS;

ANIMALIA;

EID: 79958241544     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.201012094     Document Type: Review

References (109)

1. Abtahian, F., A. Guerriero, E. Sebzda, M.M. Lu, R. Zhou, A. Mocsai, E.E. Myers, B. Huang, D.G. Jackson, V.A. Ferrari, et al. 2003. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science. 299:247-251.
2. Adams, R.H., and A. Eichmann. 2010. Axon guidance molecules in vascular patterning. Cold Spring Harb. Perspect. Biol. 2:a001875.
3. Alders, M., B.M. Hogan, E. Gjini, F. Salehi, L. Al-Gazali, E.A. Hennekam, E.E. Holmberg, M.M. Mannens, M.F. Mulder, G.J. Offerhaus, et al. 2009. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat. Genet. 41:1272-1274.
4. Au, A.C., P.A. Hernandez, E. Lieber, A.M. Nadroo, Y.M. Shen, K.A. Kelley, B.D. Gelb, and G.A. Diaz. 2010. Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans. Am. J. Hum. Genet. 87:436-444.
5. Ayadi, A., H. Zheng, P. Sobieszczuk, G. Buchwalter, P. Moerman, K. Alitalo, and B. Wasylyk. 2001. Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1. EMBO J. 20:5139-5152.
6. Bäckhed, F., P.A. Crawford, D. O'Donnell, and J.I. Gordon. 2007. Postnatal lymphatic partitioning from the blood vasculature in the small intestine requires fasting-induced adipose factor. Proc. Natl. Acad. Sci. USA. 104:606-611.
7. Baluk, P., J. Fuxe, H. Hashizume, T. Romano, E. Lashnits, S. Butz, D. Vestweber, M. Corada, C. Molendini, E. Dejana, and D.M. McDonald. 2007. Functionally specialized junctions between endothelial cells of lymphatic vessels. J. Exp. Med. 204:2349-2362.
8. Bazigou, E., S. Xie, C. Chen, A. Weston, N. Miura, L. Sorokin, R. Adams, A.F. Muro, D. Sheppard, and T. Makinen. 2009. Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev. Cell. 17:175-186.
9. Bertozzi, C.C., A.A. Schmaier, P. Mericko, P.R. Hess, Z. Zou, M. Chen, C.Y. Chen, B. Xu, M.M. Lu, D. Zhou, et al. 2010. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood. 116:661-670.
10. Böhmer, R., B. Neuhaus, S. Bühren, D. Zhang, M. Stehling, B. Böck, and F. Kiefer. 2010. Regulation of developmental lymphangiogenesis by Syk(+) leukocytes. Dev. Cell. 18:437-449.
11. Brice, G., S. Mansour, R. Bell, J.R. Collin, A.H. Child, A.F. Brady, M. Sarfarazi, K.G. Burnand, S. Jeffery, P. Mortimer, and V.A. Murday. 2002. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J. Med. Genet. 39:478-483.
12. Bussmann, J., F.L. Bos, A. Urasaki, K. Kawakami, H.J. Duckers, and S. Schulte-Merker. 2010. Arteries provide essential guidance cues for lymphatic endothelial cells in the zebrafish trunk. Development. 137:2653-2657.
13. Carramolino, L., J. Fuentes, C. García-Andrés, V. Azcoitia, D. Riethmacher, and M. Torres. 2010. Platelets play an essential role in separating the blood and lymphatic vasculatures during embryonic angiogenesis. Circ. Res. 106:1197-1201.
14. Carsillo, T., A. Astrinidis, and E.P. Henske. 2000. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc. Natl. Acad. Sci. USA. 97:6085-6090.
15. Chen, L., A. Mupo, T. Huynh, S. Cioffi, M. Woods, C. Jin, W. McKeehan, L. Thompson-Snipes, A. Baldini, and E. Illingworth. 2010. Tbx1 regulates Vegfr3 and is required for lymphatic vessel development. J. Cell Biol. 189:417-424.
16. Colucci, S., G. Taraboletti, L. Primo, A. Viale, C. Roca, D. Valdembri, M. Geuna, M. Pagano, M. Grano, A.M. Pogrel, et al. 2006. Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease. J. Bone Miner. Res. 21:207-218.
17. Dagenais, S.L., R.L. Hartsough, R.P. Erickson, M.H. Witte, M.G. Butler, and T.W. Glover. 2004. Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome. Gene Expr. Patterns. 4:611-619.
18. D'Amico, G., D.T. Jones, E. Nye, K. Sapienza, A.R. Ramjuan, L.E. Reynolds, S.D. Robinson, V. Kostourou, D. Martinez, D. Aubyn, et al. 2009. Regulation of lymphatic-blood vessel separation by endothelial Rac1. Development. 136:4043-4053.
19. D'Amico, G., E.A. Korhonen, M. Waltari, P. Saharinen, P. Laakkonen, and K. Alitalo. 2010. Loss of endothelial Tie1 receptor impairs lymphatic vessel development-brief report. Arterioscler. Thromb. Vasc. Biol. 30:207-209.
20. Danussi, C., P. Spessotto, A. Petrucco, B. Wassermann, P. Sabatelli, M. Montesi, R. Doliana, G.M. Bressan, and A. Colombatti. 2008. Emilin1 deficiency causes structural and functional defects of lymphatic vasculature. Mol. Cell. Biol. 28:4026-4039.
21. Dejana, E., F. Orsenigo, C. Molendini, P. Baluk, and D.M. McDonald. 2009. Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res. 335:17-25.
22. Dellinger, M., R. Hunter, M. Bernas, N. Gale, G. Yancopoulos, R. Erickson, and M. Witte. 2008. Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice. Dev. Biol. 319:309-320.
23. Fang, J., S.L. Dagenais, R.P. Erickson, M.F. Arlt, M.W. Glynn, J.L. Gorski, L.H. Seaver, and T.W. Glover. 2000. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am. J. Hum. Genet. 67:1382-1388.
24. Ferrell, R.E., C.J. Baty, M.A. Kimak, J.M. Karlsson, E.C. Lawrence, M. Franke-Snyder, S.D. Meriney, E. Feingold, and D.N. Finegold. 2010. GJC2 missense mutations cause human lymphedema. Am. J. Hum. Genet. 86:943-948.
25. Földi, M., E. Földi, R.H.K. Strößenreuther, and S. Kubic, editors. 2006. Földi's Textbook of Lymphology: For Physicians and Lymphedema Therapists. Second edition. Urban and Fischer, Munich. 736 pp..
26. François, M., A. Caprini, B. Hosking, F. Orsenigo, D. Wilhelm, C. Browne, K. Paavonen, T. Karnezis, R. Shayan, M. Downes, et al. 2008. Sox18 induces development of the lymphatic vasculature in mice. Nature. 456:643-647.
27. Fritz-Six, K.L., W.P. Dunworth, M. Li, and K.M. Caron. 2008. Adrenomedullin signaling is necessary for murine lymphatic vascular development. J. Clin. Invest. 118:40-50.
28. Fu, J., H. Gerhardt, J.M. McDaniel, B. Xia, X. Liu, L. Ivanciu, A. Ny, K. Hermans, R. Silasi-Mansat, S. McGee, et al. 2008. Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J. Clin. Invest. 118:3725-3737.
29. Gale, N.W., G. Thurston, S.F. Hackett, R. Renard, Q. Wang, J. McClain, C. Martin, C. Witte, M.H. Witte, D. Jackson, et al. 2002. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev. Cell. 3:411-423.
30. Geudens, I., R. Herpers, K. Hermans, I. Segura, C. Ruiz de Almodovar, J. Bussmann, F. De Smet, W. Vandevelde, B.M. Hogan, A. Siekmann, et al. 2010. Role of delta-like-4/Notch in the formation and wiring of the lymphatic network in zebrafish. Arterioscler. Thromb. Vasc. Biol. 30:1695- 1702.
31. Gjini, E., L.H. Hekking, A. Küchler, P. Saharinen, E. Wienholds, J.A. Post, K. Alitalo, and S. Schulte-Merker. 2011. Zebrafish Tie-2 shares a redundant role with Tie-1 in heart development and regulates vessel integrity. Dis Model Mech. 4:57-66.
32. Glasgow, C.G., W.K. Steagall, A. Taveira-Dasilva, G. Pacheco-Rodriguez, X. Cai, S. El-Chemaly, M. Moses, T. Darling, and J. Moss. 2010. Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies. Respir. Med. 104(Suppl. 1):S45-S58.
33. Gordon, E.J., S. Rao, J.W. Pollard, S.L. Nutt, R.A. Lang, and N.L. Harvey. 2010. Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation. Development. 137:3899-3910.
34. Gupta, S., A.R. Ramjaun, P. Haiko, Y. Wang, P.H. Warne, B. Nicke, E. Nye, G. Stamp, K. Alitalo, and J. Downward. 2007. Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice. Cell. 129:957-968.
35. Hagendoorn, J., T.P. Padera, T.I. Yock, G.P. Nielsen, E. di Tomaso, D.G. Duda, T.F. Delaney, H.A. Gaissert, J. Pearce, A.E. Rosenberg, et al. 2006. Platelet-derived growth factor receptor-beta in Gorham's disease. Nat. Clin. Pract. Oncol. 3:693-697.
36. Haiko, P., T. Makinen, S. Keskitalo, J. Taipale, M.J. Karkkainen, M.E. Baldwin, S.A. Stacker, M.G. Achen, and K. Alitalo. 2008. Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos. Mol. Cell. Biol. 28:4843- 4850.
37. Hansen, A., S. Henderson, D. Lagos, L. Nikitenko, E. Coulter, S. Roberts, F. Gratrix, K. Plaisance, R. Renne, M. Bower, et al. 2010. KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. Genes Dev. 24:195-205.
38. Harvey, N.L., R.S. Srinivasan, M.E. Dillard, N.C. Johnson, M.H. Witte, K. Boyd, M.W. Sleeman, and G. Oliver. 2005. Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat. Genet. 37:1072-1081.
39. Hermans, K., F. Claes, W. Vandevelde, W. Zheng, I. Geudens, F. Orsenigo, F. De Smet, E. Gjini, K. Anthonis, B. Ren, et al. 2010. Role of synectin in lymphatic development in zebrafish and frogs. Blood. 116:3356-3366.
40. Hirashima, M., K. Sano, T. Morisada, K. Murakami, J. Rossant, and T. Suda. 2008. Lymphatic vessel assembly is impaired in Aspp1-deficient mouse embryos. Dev. Biol. 316:149-159.
41. Hirayama, T., A. Sabokbar, I. Itonaga, S. Watt-Smith, and N.A. Athanasou. 2001. Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease. J. Pathol. 195:624-630.
42. Hogan, B.M., F.L. Bos, J. Bussmann, M. Witte, N.C. Chi, H.J. Duckers, and S. Schulte-Merker. 2009a. Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting. Nat. Genet. 41:396-398.
43. Hogan, B.M., R. Herpers, M. Witte, H. Heloterä, K. Alitalo, H.J. Duckers, and S. Schulte-Merker. 2009b. Vegfc/Flt4 signalling is suppressed by Dll4 in developing zebrafish intersegmental arteries. Development. 136:4001-4009.
44. Hong, Y.K., N. Harvey, Y.H. Noh, V. Schacht, S. Hirakawa, M. Detmar, and G. Oliver. 2002. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev. Dyn. 225:351-357.
45. Hong, Y.K., K. Foreman, J.W. Shin, S. Hirakawa, C.L. Curry, D.R. Sage, T. Libermann, B.J. Dezube, J.D. Fingeroth, and M. Detmar. 2004. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat. Genet. 36:683-685.
46. Ichise, H., T. Ichise, O. Ohtani, and N. Yoshida. 2009. Phospholipase Cgamma2 is necessary for separation of blood and lymphatic vasculature in mice. Development. 136:191-195.
47. Irrthum, A., K. Devriendt, D. Chitayat, G. Matthijs, C. Glade, P.M. Steijlen, J.P. Fryns, M.A. Van Steensel, and M. Vikkula. 2003. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am. J. Hum. Genet. 72:1470-1478.
48. Johnson, N.C., M.E. Dillard, P. Baluk, D.M. McDonald, N.L. Harvey, S.L. Frase, and G. Oliver. 2008. Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes Dev. 22:3282-3291.
49. Kaipainen, A., J. Korhonen, T. Mustonen, V.W. van Hinsbergh, G.-H. Fang, D. Dumont, M. Breitman, and K. Alitalo. 1995. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA. 92:3566-3570.
50. Kampmeier, O.F. 1969. Evolution and Comparative Morphology of the Lymphatic System. Charles C. Thomas, Springfield, IL. 620 pp.
51. Karkkainen, M.J., R.E. Ferrell, E.C. Lawrence, M.A. Kimak, K.L. Levinson, M.A. McTigue, K. Alitalo, and D.N. Finegold. 2000. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat. Genet. 25:153-159.
52. Karkkainen, M.J., A. Saaristo, L. Jussila, K.A. Karila, E.C. Lawrence, K. Pajusola, H. Bueler, A. Eichmann, R. Kauppinen, M.I. Kettunen, et al. 2001. A model for gene therapy of human hereditary lymphedema. Proc. Natl. Acad. Sci. USA. 98:12677-12682.
53. Karkkainen, M.J., P. Haiko, K. Sainio, J. Partanen, J. Taipale, T.V. Petrova, M. Jeltsch, D.G. Jackson, M. Talikka, H. Rauvala, et al. 2003. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5:74-80.
54. Kärpänen, T., C.A. Heckman, S. Keskitalo, M. Jeltsch, H. Ollila, G. Neufeld, L. Tamagnone, and K. Alitalo. 2006a. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J. 20:1462-1472.
55. Kärpänen, T., M. Wirzenius, T. Mäkinen, T. Veikkola, H.J. Haisma, M.G. Achen, S.A. Stacker, B. Pytowski, S. Ylä-Herttuala, and K. Alitalo. 2006b. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am. J. Pathol. 169:708-718.
56. Küchler, A.M., E. Gjini, J. Peterson-Maduro, B. Cancilla, H. Wolburg, and S. Schulte-Merker. 2006. Development of the zebrafish lymphatic system requires VEGFC signaling. Curr. Biol. 16:1244-1248.
57. Kuhnert, F., L. Campagnolo, J.W. Xiong, D. Lemons, M.J. Fitch, Z. Zou, W.B. Kiosses, H. Gardner, and H. Stuhlmann. 2005. Dosage-dependent requirement for mouse Vezf1 in vascular system development. Dev. Biol. 283:140-156.
58. Lauweryns, J.M., and L. Boussauw. 1973. The ultrastructure of lymphatic valves in the adult rabbit lung. Z. Zellforsch. Mikrosk. Anat. 143:149-168.
59. Leak, L.V., and J.F. Burke. 1968. Ultrastructural studies on the lymphatic anchoring filaments. J. Cell Biol. 36:129-149.
60. Lee, S., J. Kang, J. Yoo, S.K. Ganesan, S.C. Cook, B. Aguilar, S. Ramu, J. Lee, and Y.K. Hong. 2009. Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate. Blood. 113:1856- 1859.
61. Liao, S., T.P. Padera, and R.K. Jain. 2010. Notch leads lymphatics and links them to blood vessels. Arterioscler. Thromb. Vasc. Biol. 30:1682-1683.
62. Lichtenstein, L., F. Mattijssen, N.J. de Wit, A. Georgiadi, G.J. Hooiveld, R. van der Meer, Y. He, L. Qi, A. Köster, J.T. Tamsma, et al. 2010. Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages. Cell Metab. 12:580-592.
63. Lin, F.J., X. Chen, J. Qin, Y.K. Hong, M.J. Tsai, and S.Y. Tsai. 2010. Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development. J. Clin. Invest. 120:1694- 1707.
64. Mäkinen, T., L. Jussila, T. Veikkola, T. Kärpänen, M.I. Kettunen, K.J. Pulkkanen, R. Kauppinen, D.G. Jackson, H. Kubo, S.-I. Nishikawa, et al. 2001. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat. Med. 7:199-205.
65. Mäkinen, T., R.H. Adams, J. Bailey, Q. Lu, A. Ziemiecki, K. Alitalo, R. Klein, and G.A. Wilkinson. 2005. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 19:397-410.
66. Mellor, R.H., G. Brice, A.W. Stanton, J. French, A. Smith, S. Jeffery, J.R. Levick, K.G. Burnand, and P.S. Mortimer Lymphoedema Research Consortium. 2007. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation. 115:1912-1920.
67. Mellor, R.H., C.E. Hubert, A.W. Stanton, N. Tate, V. Akhras, A. Smith, K.G. Burnand, S. Jeffery, T. Mäkinen, J.R. Levick, and P.S. Mortimer. 2010. Lymphatic dysfunction, not aplasia, underlies Milroy disease. Microcirculation. 17:281-296.
68. Mesri, E.A., E. Cesarman, and C. Boshoff. 2010. Kaposi's sarcoma and its associated herpesvirus. Nat. Rev. Cancer. 10:707-719.
69. Miteva, D.O., J.M. Rutkowski, J.B. Dixon, W. Kilarski, J.D. Shields, and M.A. Swartz. 2010. Transmural flow modulates cell and fluid transport functions of lymphatic endothelium. Circ. Res. 106:920-931.
70. Mouta-Bellum, C., A. Kirov, L. Miceli-Libby, M.L. Mancini, T.V. Petrova, L. Liaw, I. Prudovsky, P.E. Thorpe, N. Miura, L.C. Cantley, et al. 2009. Organspecific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha. Dev. Dyn. 238:2670-2679.
71. Muthuchamy, M., A. Gashev, N. Boswell, N. Dawson, and D. Zawieja. 2003. Molecular and functional analyses of the contractile apparatus in lymphatic muscle. FASEB J. 17:920-922.
72. Nilsson, I., F. Bahram, X. Li, L. Gualandi, S. Koch, M. Jarvius, O. Söderberg, A. Anisimov, I. Kholová, B. Pytowski, et al. 2010. VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J. 29:1377-1388.
73. Norrmén, C., K.I. Ivanov, J. Cheng, N. Zangger, M. Delorenzi, M. Jaquet, N. Miura, P. Puolakkainen, V. Horsley, J. Hu, et al. 2009. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J. Cell Biol. 185:439-457.
74. Ny, A., M. Koch, M. Schneider, E. Neven, R.T. Tong, S. Maity, C. Fischer, S. Plaisance, D. Lambrechts, C. Héligon, et al. 2005. A genetic Xenopus laevis tadpole model to study lymphangiogenesis. Nat. Med. 11:998-1004.
75. Pacheco-Rodriguez, G., F. Kumaki, W.K. Steagall, Y. Zhang, Y. Ikeda, J.P. Lin, E.M. Billings, and J. Moss. 2009. Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene. J. Immunol. 182:1270-1277.
76. Pennisi, D., J. Bowles, A. Nagy, G. Muscat, and P. Koopman. 2000. Mice null for sox18 are viable and display a mild coat defect. Mol. Cell. Biol. 20:9331-9336.
77. Petrova, T.V., T. Mäkinen, T.P. Mäkelä, J. Saarela, I. Virtanen, R.E. Ferrell, D.N. Finegold, D. Kerjaschki, S. Ylä-Herttuala, and K. Alitalo. 2002. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 21:4593-4599.
78. Petrova, T.V., T. Kärpänen, C. Norrmén, R. Mellor, T. Tamakoshi, D. Finegold, R. Ferrell, D. Kerjaschki, P. Mortimer, S. Ylä-Herttuala, et al. 2004. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 10:974-981.
79. Pflicke, H., and M. Sixt. 2009. Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J. Exp. Med. 206:2925-2935.
80. Radhakrishnan, K., and S.G. Rockson. 2008. Gorham's disease: an osseous disease of lymphangiogenesis? Ann. NY Acad. Sci. 1131:203-205.
81. Rockson, S.G. 2001. Lymphedema. Am. J. Med. 110:288-295.
82. Rockson, S.G. 2008. Secondary lymphedema: is it a primary disease? Lymphat. Res. Biol. 6:63-64.
83. Sabin, F.R. 1902. On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am. J. Anat. 1:367-391.
84. Saharinen, P., H. Helotera, J. Miettinen, C. Norrmen, G. D'Amico, M. Jeltsch, T. Langenberg, W. Vandevelde, A. Ny, M. Dewerchin, et al. 2010. Claudinlike protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development. Genes Dev. 24:875-880.
85. Sato, T., K. Seyama, H. Fujii, H. Maruyama, Y. Setoguchi, S. Iwakami, Y. Fukuchi, and O. Hino. 2002. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. J. Hum. Genet. 47:20-28.
86. Schacht, V., M.I. Ramirez, Y.K. Hong, S. Hirakawa, D. Feng, N. Harvey, M. Williams, A.M. Dvorak, H.F. Dvorak, G. Oliver, and M. Detmar. 2003. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22:3546-3556.
87. Seyama, K., T. Kumasaka, M. Kurihara, K. Mitani, and T. Sato. 2010. Lymphan gioleiomyomatosis: a disease involving the lymphatic system. Lymphat. Res. Biol. 8:21-31.
88. Sleeman, J., A. Schmid, and W. Thiele. 2009. Tumor lymphatics. Semin. Cancer Biol. 19:285-297.
89. Srinivasan, R.S., M.E. Dillard, O.V. Lagutin, F.J. Lin, S. Tsai, M.J. Tsai, I.M. Samokhvalov, and G. Oliver. 2007. Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes Dev. 21:2422-2432.
90. Srinivasan, R.S., X. Geng, Y. Yang, Y. Wang, S. Mukatira, M. Studer, M.P. Porto, O. Lagutin, and G. Oliver. 2010. The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes Dev. 24:696-707.
91. Suzuki-Inoue, K., O. Inoue, G. Ding, S. Nishimura, K. Hokamura, K. Eto, H. Kashiwagi, Y. Tomiyama, Y. Yatomi, K. Umemura, et al. 2010. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J. Biol. Chem. 285:24494-24507.
92. Tammela, T., and K. Alitalo. 2010. Lymphangiogenesis: Molecular mechanisms and future promise. Cell. 140:460-476.
93. Taniguchi, K., R. Kohno, T. Ayada, R. Kato, K. Ichiyama, T. Morisada, Y. Oike, Y. Yonemitsu, Y. Maehara, and A. Yoshimura. 2007. Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling. Mol. Cell. Biol. 27:4541-4550.
94. Uhrin, P., J. Zaujec, J.M. Breuss, D. Olcaydu, P. Chrenek, H. Stockinger, E. Fuertbauer, M. Moser, P. Haiko, R. Fässler, et al. 2010. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood. 115:3997-4005.
95. van Steensel, M.A., R.J. Damstra, M.V. Heitink, R.S. Bladergroen, J. Veraart, P.M. Steijlen, and M. van Geel. 2009. Novel missense mutations in the FOXC2 gene alter transcriptional activity. Hum. Mutat. 30:E1002-E1009.
96. Wang, H.W., M.W. Trotter, D. Lagos, D. Bourboulia, S. Henderson, T. Mäkinen, S. Elliman, A.M. Flanagan, K. Alitalo, and C. Boshoff. 2004. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat. Genet. 36:687-693.
97. Wang, Y., M. Nakayama, M.E. Pitulescu, T.S. Schmidt, M.L. Bochenek, A. Sakakibara, S. Adams, A. Davy, U. Deutsch, U. Lüthi, et al. 2010. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature. 465:483-486.
98. Wigle, J.T., and G. Oliver. 1999. Prox1 function is required for the development of the murine lymphatic system. Cell. 98:769-778.
99. Wigle, J.T., K. Chowdhury, P. Gruss, and G. Oliver. 1999. Prox1 function is crucial for mouse lens-fibre elongation. Nat. Genet. 21:318-322.
100. Wirzenius, M., T. Tammela, M. Uutela, Y. He, T. Odorisio, G. Zambruno, J.A. Nagy, H.F. Dvorak, S. Ylä-Herttuala, M. Shibuya, and K. Alitalo. 2007. Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J. Exp. Med. 204:1431-1440.
101. Xu, Y., L. Yuan, J. Mak, L. Pardanaud, M. Caunt, I. Kasman, B. Larrivée, R. Del Toro, S. Suchting, A. Medvinsky, et al. 2010. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J. Cell Biol. 188:115-130.
102. Yamazaki, T., Y. Yoshimatsu, Y. Morishita, K. Miyazono, and T. Watabe. 2009. COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction. Genes Cells. 14:425-434.
103. Yaniv, K., S. Isogai, D. Castranova, L. Dye, J. Hitomi, and B.M. Weinstein. 2006. Live imaging of lymphatic development in the zebrafish. Nat. Med. 12:711-716.
104. Yoo, J., J. Kang, H.N. Lee, B. Aguilar, D. Kafka, S. Lee, I. Choi, J. Lee, S. Ramu, J. Haas, et al. 2010. Kaposin-B enhances the PROX1 mRNA stability during lymphatic reprogramming of vascular endothelial cells by Kaposi's sarcoma herpes virus. PLoS Pathog. 6: e1001046.
105. Yu, J.J., V.A. Robb, T.A. Morrison, E.A. Ariazi, M. Karbowniczek, A. Astrinidis, C. Wang, L. Hernandez-Cuebas, L.F. Seeholzer, E. Nicolas, et al. 2009. Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells. Proc. Natl. Acad. Sci. USA. 106:2635-2640.
106. Yuan, L., D. Moyon, L. Pardanaud, C. Bréant, M.J. Karkkainen, K. Alitalo, and A. Eichmann. 2002. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development. 129:4797-4806.
107. Zawieja, D.C. 2009. Contractile physiology of lymphatics. Lymphat. Res. Biol. 7:87-96.
108. Zhang, L., F. Zhou, W. Han, B. Shen, J. Luo, M. Shibuya, and Y. He. 2010. VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis. Cell Res. 20:1319-1331.
109. Zhou, F., Z. Chang, L. Zhang, Y.K. Hong, B. Shen, B. Wang, F. Zhang, G. Lu, D. Tvorogov, K. Alitalo, et al. 2010. Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development. Am. J. Pathol. 177:2124-2133.